As of May 22
| -0.17 / -0.38%|
The 11 analysts offering 12-month price forecasts for Thoratec Corp have a median target of 46.00, with a high estimate of 55.00 and a low estimate of 41.00. The median estimate represents a +2.27% increase from the last price of 44.98.
The current consensus among 14 polled investment analysts is to Hold stock in Thoratec Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.